Are reverse payments and pay-for-delay settlements business as usual or an anticompetitive practice?

被引:1
|
作者
Shah, Swati [1 ]
Silva, Matthew A. [1 ]
Malloy, Michael J. [1 ]
机构
[1] MCPHS Univ, Worcester, MA USA
关键词
D O I
10.1038/nbt.3627
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cash payments and other arrangements between patent holders and their competitors in exchange for a delayed market entry interfere with free-market principles and keep product prices at a premium, which affects payers, governments, healthcare providers and especially patients.
引用
收藏
页码:716 / 719
页数:4
相关论文
共 10 条
  • [1] Are reverse payments and pay-for-delay settlements business as usual or an anticompetitive practice?
    Swati Shah
    Matthew A Silva
    Michael J Malloy
    [J]. Nature Biotechnology, 2016, 34 : 716 - 719
  • [2] Do "Reverse Payment" Settlements Constitute an Anticompetitive Pay-for-Delay?
    Drake, Keith
    Starr, Martha
    McGuire, Thomas
    [J]. INTERNATIONAL JOURNAL OF THE ECONOMICS OF BUSINESS, 2015, 22 (02) : 173 - 200
  • [3] 'Pay-for-Delay' Settlements: In Search of the Right Standard
    de Margerie, Stanislas
    [J]. WORLD COMPETITION, 2013, 36 (01): : 85 - 97
  • [4] Pay-for-delay settlements and patent expansion practices
    Manganelli, Anton-Giulio
    [J]. INFORMATION ECONOMICS AND POLICY, 2023, 64
  • [5] Federal Trade Commission v. Actavis, Inc. and reverse-payment or pay-for-delay settlements
    Sherkow, Jacob S.
    [J]. NATURE BIOTECHNOLOGY, 2013, 31 (04) : 316 - 318
  • [6] Federal Trade Commission v. Actavis, Inc. and reverse-payment or pay-for-delay settlements
    Jacob S Sherkow
    [J]. Nature Biotechnology, 2013, 31 : 316 - 317
  • [7] Pharmaceutical "Pay-for-Delay" Reexamined: A Dwindling Practice or a Persistent Problem?
    Karas, Laura
    Anderson, Gerard F.
    Feldman, Robin
    [J]. HASTINGS LAW JOURNAL, 2020, 71 (04) : 959 - 974
  • [8] Whistling Past the Graveyard: The Problem with the Per Se Legality Treatment of Pay-for-Delay Settlements
    Kades, Michael
    [J]. COMPETITION POLICY INTERNATIONAL, 2009, 5 (02): : 143 - 163
  • [9] AN EVENT STUDY OF PERINDOPRIL (SERVIER) REVERSE PAYMENT PATENT SETTLEMENTS' CASE: IS KRKA TRULY AN EXCEPTION WITHIN THE PAY-FOR-DELAY COMMISSION DECISION?
    Ocepek, France
    [J]. LEXONOMICA, 2023, 15 (01): : 121 - 146
  • [10] Activating Actavis in Europe - the proposal of a "structured effects-based' analysis for pay-for-delay settlements
    Gallasch, Sven
    [J]. LEGAL STUDIES, 2016, 36 (04) : 683 - 705